Article 1. Name and Headquarters. Applicable law

1.1. The Experts Group on Inositol in Basic and Clinical Research, and on PCOS (hereinafter “EGOI-PCOS”) is hereby established.

1.2. EGOI-PCOS is headquartered in Rome, Italy.

1.3. The relationship between EGOI-PCOS and its members shall be governed exclusively by law and by these Articles of Association.

Article 2. Objectives

2.1. EGOI-PCOS brings together several international researchers, clinicians and opinion leaders, skilled in the field of inositol physiology and treatment, and in Polycystic Ovary Syndrome (PCOS) pathophysiology and therapy with the aim to debate, unravel and share scientific content on these topics, relating to their own expertise in the field.

The aforesaid objectives shall be implemented by:

(a) promoting and disseminating studies and knowledge about all matters linked to the clinical use of inositols in medicine, in order to obtain a higher level of general health, using the appropriate means.

(b) promoting and disseminating studies and knowledge about all matters linked to PCOS pathophysiology and therapy.

(c) drafting Guidelines and Standards for a tailored therapy of PCOS in order to promote a higher level of general health.

(d) fostering interdisciplinary collaboration between those personalities and societies involved in studying and working on PCOS characterization, as well as on the use of inositol in medicine and in healthcare for the individual.

2.2. The aforesaid objectives may be met in the following ways:

  1. a) by organizing an EGOI-PCOS Meeting at least every two years (circumstances permitting) in different geographical countries, where EGOI-PCOS members operate.
  2. b) by creating and supporting study groups working on topics of special interest.
  3. c) by encouraging and facilitating the circulation of knowledge and information in scientific publications, by means of a dedicated website.
  4. d) by appointing work groups to coordinate clinical trials conducted in various facilities.
  5. e) by promoting the acknowledgment of internationally accepted definitions, terminology, and methodologies.

Article 3. Duration, official language, and communications addressed to members

3.1. EGOI shall be of unlimited duration.

3.2. EGOI official language is English. However, a lack of knowledge of the English language shall not compromise one’s possibility of becoming a member of the society.

Article 4. Membership

4.1. Membership of EGOI-PCOS is open to all scientific personalities who adhere to the mission and objectives of the group.

4.2. Involvement in EGOI-PCOS is possible in the following ways:
(a) researchers, practitioners, and opinion leaders should have at least 3 original papers about inositol physiology and/or therapy and /or about PCOS that have been published in the last five years in scientific journals with impact factor.
(b) recommendation by at least two senior EGOI-PCOS members is mandatory for prospective members.
(c) to maintain active membership yearly contributions (such as book chapters, reviews, and original papers on inositol and/or PCOS) are required.
(d) members are highly encouraged to provide suggestions, concerns, and issues on PCOS tailored treatment.
(e) in any case, each membership request will require approval from an executive board.

Article 5. EGOI structure

The Society is composed of:

• EGOI-PCOS co-founders: Prof. Vittorio Unfer and Prof. Fabio Facchinetti.

• Senior EGOI-PCOS members
• EGOI-PCOS members

Member and Senior Member grades recognize those who have achieved professional proficiency, as demonstrated by degrees received and/or work experience.
Senior EGOI-PCOS members should have published at least 5 original papers on the topic.

• Secretariat: Miss Valentina Gattaino ( is in charge of coordinating the activities of the group.